News
Featured
The event will review best practices for care and management of patients with inherited retinal diseases such as retinitis pigmentosa, Usher syndrome, and Stargardt disease.
Recent News
-
Foundation Fighting Blindness Commits $6.5 Million for New Retinal Disease Research Grants
New grants include development of CRISPR/Cas9 gene-editing treatments, new disease models, and a retinal regeneration therapy
-
This exclusive conversation and acoustic performance by Sam and Casey Harris of X Ambassadors on August 20, will raise awareness and funds to find treatments and cures for blinding diseases.
-
Foundation Fighting Blindness and the Retinal Degeneration Fund
In 2018, the Foundation Fighting Blindness launched a venture philanthropy investment arm called the Retinal Degeneration (RD) Fund to help companies and researchers advance promising treatments for inherited retinal diseases into and through early-stage human studies. Currently, the RD Fund has allocated about 75% of its $72 million fund to eight investments.
-
Fighting Blindness Insights Forum Call - July 30, 2020
The Foundation Fighting Blindness is pleased to provide an audio recording and full transcripts of the Insights Forum, our quarterly conference call providing updates to the inherited retinal disease community. The call took place on July 30, 2020.
-
Company formed with $8.15 million Series 1; led by founding investors Hatteras Venture Partners and the Foundation Fighting Blindness
-
Accepting grant applications for advancing retinal degeneration treatments toward human studies
-
Foundation Fighting Blindness to Host Virtual VISIONS 2020 Conference
The national conference will be held virtually on June 25-27, providing the latest in science and research, practical adapting and thriving, and an opportunity to connect with others who are visually impaired.
-
Inherited Retinal Disease Genetic Testing Webinar-Workshop for Eye Care Professionals
Hosted by the Foundation Fighting Blindness, Blueprint Genetics, and InformedDNA June 4, 2020, 12:00 p.m.–1:30 p.m. ET
-
Enhancements include streamlined data entry, improved site navigation, better accessibility for low-vision users, and efficient integration with mobile technology.
-
Foundation and Vision Partners Seek Biomedical Research Support from Congress during COVID-19 Crisis
Delays in Research Impacting Therapy Development
